drug · protein
interferon alpha
Phase 2updated 5mo agoby $AIMD Ainos, Inc.🔗 ChEMBL
Phase 2community read0 votes
Protein drug with a maximum clinical stage of Approval (across all indications), with an approval for hiv infection and 7 investigational indications.
targets
Interferon alpha/beta receptor
all catalysts(0)
nothing on the calendar yet
Trials studying interferon alpha
- phase2Efficacy of Prazosin Versus Placebo Associated With Peg-interferon Alpha 2b and Ribavirin in Chronic Hepatitis C With Genotype 1 or 4 and Severe Fibrosis
- phase2Therapy With Asunaprevir, Daclatasvir, Ribavirin and Pegylated Interferon Alpha-2a in HCV Genotype 4-infected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin (ANRS HC32 QUATTRO)
- phase2Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus (HBV)
- —Replicor Compassionate Access Program
- phase2Pegylated Interferon Alfa-2b and Nilotinib for Augmentation of Complete Molecular Response in Chronic Myeloid Leukaemia
- phase2Safety, Tolerability, and Antiviral Activity of ACH-0141625 or Placebo in Combination With Peginterferon and Ribavirin in Hepatitis C Virus (HCV) Positive Participants
- phase2Pilot Peg-Interferon-a2b in Decreasing Viral DNA in HIV
News(1)
- ‘We’re moving quickly’: Startup bags rare disease drug as Thiel-backed CEO eyes $50M fundraiseA rare disease startup with a mission to repurpose proven drugs has licensed a Chinese formulation of a well-known medicine and set its sights on a $50 million fundraise.fiercebiotech · 2mo ago
Data sources
last refreshed just now
Found something off?
comments(0)
5-min edit window · permanent after that